JP7333679B2 - 医療支援装置、医療支援方法及び医療支援プログラム - Google Patents
医療支援装置、医療支援方法及び医療支援プログラム Download PDFInfo
- Publication number
- JP7333679B2 JP7333679B2 JP2023047490A JP2023047490A JP7333679B2 JP 7333679 B2 JP7333679 B2 JP 7333679B2 JP 2023047490 A JP2023047490 A JP 2023047490A JP 2023047490 A JP2023047490 A JP 2023047490A JP 7333679 B2 JP7333679 B2 JP 7333679B2
- Authority
- JP
- Japan
- Prior art keywords
- user
- terminal
- patient
- goal
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims description 37
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 399
- 201000010099 disease Diseases 0.000 claims description 396
- 230000006872 improvement Effects 0.000 claims description 149
- 230000009471 action Effects 0.000 claims description 96
- 238000012360 testing method Methods 0.000 claims description 85
- 208000001145 Metabolic Syndrome Diseases 0.000 claims description 46
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims description 46
- 230000003542 behavioural effect Effects 0.000 claims description 25
- 230000004044 response Effects 0.000 claims description 23
- 230000035622 drinking Effects 0.000 claims description 17
- 230000000391 smoking effect Effects 0.000 claims description 17
- 238000007689 inspection Methods 0.000 claims description 16
- 235000006694 eating habits Nutrition 0.000 claims description 6
- 230000004622 sleep time Effects 0.000 claims description 4
- 230000009467 reduction Effects 0.000 claims description 3
- 230000006399 behavior Effects 0.000 claims description 2
- 239000002131 composite material Substances 0.000 description 46
- 238000010586 diagram Methods 0.000 description 31
- 206010020772 Hypertension Diseases 0.000 description 23
- 238000012545 processing Methods 0.000 description 23
- 208000032928 Dyslipidaemia Diseases 0.000 description 20
- 208000017170 Lipid metabolism disease Diseases 0.000 description 20
- 206010012601 diabetes mellitus Diseases 0.000 description 20
- 230000002354 daily effect Effects 0.000 description 19
- 210000004369 blood Anatomy 0.000 description 15
- 239000008280 blood Substances 0.000 description 15
- 208000008589 Obesity Diseases 0.000 description 14
- 230000006870 function Effects 0.000 description 14
- 235000020824 obesity Nutrition 0.000 description 14
- 210000000056 organ Anatomy 0.000 description 13
- 235000012054 meals Nutrition 0.000 description 11
- 230000007704 transition Effects 0.000 description 11
- 238000008214 LDL Cholesterol Methods 0.000 description 10
- 230000035487 diastolic blood pressure Effects 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 230000035488 systolic blood pressure Effects 0.000 description 10
- 230000036772 blood pressure Effects 0.000 description 9
- 238000004364 calculation method Methods 0.000 description 8
- 230000036541 health Effects 0.000 description 8
- 208000029078 coronary artery disease Diseases 0.000 description 7
- 238000012552 review Methods 0.000 description 7
- 230000002159 abnormal effect Effects 0.000 description 6
- 208000026106 cerebrovascular disease Diseases 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 235000005911 diet Nutrition 0.000 description 6
- 230000037213 diet Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 238000004891 communication Methods 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 235000005686 eating Nutrition 0.000 description 4
- 210000001596 intra-abdominal fat Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 238000002562 urinalysis Methods 0.000 description 4
- 206010012289 Dementia Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 230000003187 abdominal effect Effects 0.000 description 3
- 238000009534 blood test Methods 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- 230000002485 urinary effect Effects 0.000 description 3
- 238000012935 Averaging Methods 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 108010023302 HDL Cholesterol Proteins 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 238000003066 decision tree Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000001508 eye Anatomy 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 230000001631 hypertensive effect Effects 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000008450 motivation Effects 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010007556 Cardiac failure acute Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 238000013528 artificial neural network Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 238000004422 calculation algorithm Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000008338 non-alcoholic fatty liver disease Diseases 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000004203 pancreatic function Effects 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 238000004313 potentiometry Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000007637 random forest analysis Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 201000002859 sleep apnea Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000007103 stamina Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Images
Landscapes
- Medical Treatment And Welfare Office Work (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021214424 | 2021-12-28 | ||
| JP2021214424 | 2021-12-28 | ||
| JP2023518075A JP7479103B2 (ja) | 2021-12-28 | 2022-12-09 | 医療支援装置、医療支援方法及び医療支援プログラム |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023518075A Division JP7479103B2 (ja) | 2021-12-28 | 2022-12-09 | 医療支援装置、医療支援方法及び医療支援プログラム |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023098732A JP2023098732A (ja) | 2023-07-10 |
| JP2023098732A5 JP2023098732A5 (https=) | 2023-07-25 |
| JP7333679B2 true JP7333679B2 (ja) | 2023-08-25 |
Family
ID=87074442
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023047490A Active JP7333679B2 (ja) | 2021-12-28 | 2023-03-24 | 医療支援装置、医療支援方法及び医療支援プログラム |
| JP2023145349A Pending JP2023158148A (ja) | 2021-12-28 | 2023-09-07 | 医療支援装置、医療支援方法及び医療支援プログラム |
| JP2024028893A Pending JP2024052717A (ja) | 2021-12-28 | 2024-02-28 | 医療支援装置、医療支援方法及び医療支援プログラム |
| JP2024028903A Pending JP2024052718A (ja) | 2021-12-28 | 2024-02-28 | 医療支援装置、医療支援方法及び医療支援プログラム |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023145349A Pending JP2023158148A (ja) | 2021-12-28 | 2023-09-07 | 医療支援装置、医療支援方法及び医療支援プログラム |
| JP2024028893A Pending JP2024052717A (ja) | 2021-12-28 | 2024-02-28 | 医療支援装置、医療支援方法及び医療支援プログラム |
| JP2024028903A Pending JP2024052718A (ja) | 2021-12-28 | 2024-02-28 | 医療支援装置、医療支援方法及び医療支援プログラム |
Country Status (1)
| Country | Link |
|---|---|
| JP (4) | JP7333679B2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026042718A1 (ja) * | 2024-08-19 | 2026-02-26 | サスメド株式会社 | 認知行動療法支援装置、認知行動療法支援システムおよび認知行動療法支援プログラム |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006304833A (ja) | 2005-04-26 | 2006-11-09 | Sysmex Corp | 診断支援システム及びコンピュータプログラム |
| JP2008176434A (ja) | 2007-01-17 | 2008-07-31 | Hitachi Medical Corp | 個別健康指導支援システム |
| JP2010250489A (ja) | 2009-04-14 | 2010-11-04 | Hitachi Medical Corp | メタボリックシンドローム改善情報演算システム、当該システムとして機能させるためのプログラム、及び、当該プログラムを記録した記録媒体 |
| JP2013109700A (ja) | 2011-11-24 | 2013-06-06 | Zenrin Datacom Co Ltd | 健康管理支援装置、健康管理支援方法および健康管理支援プログラム |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012064087A (ja) * | 2010-09-17 | 2012-03-29 | Keio Gijuku | 生活習慣病の診断予測装置、生活習慣病の診断予測方法及びプログラム |
| JP2017040981A (ja) * | 2015-08-17 | 2017-02-23 | 国立大学法人東北大学 | 健康情報処理装置、健康情報処理方法、健康情報処理プログラム、健康情報表示装置、健康情報表示方法、及び健康情報表示プログラム |
| JP6894624B2 (ja) * | 2016-08-18 | 2021-06-30 | メドケア株式会社 | 遠隔診療支援システム、遠隔診療支援サーバ及び遠隔診療支援方法 |
-
2023
- 2023-03-24 JP JP2023047490A patent/JP7333679B2/ja active Active
- 2023-09-07 JP JP2023145349A patent/JP2023158148A/ja active Pending
-
2024
- 2024-02-28 JP JP2024028893A patent/JP2024052717A/ja active Pending
- 2024-02-28 JP JP2024028903A patent/JP2024052718A/ja active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006304833A (ja) | 2005-04-26 | 2006-11-09 | Sysmex Corp | 診断支援システム及びコンピュータプログラム |
| JP2008176434A (ja) | 2007-01-17 | 2008-07-31 | Hitachi Medical Corp | 個別健康指導支援システム |
| JP2010250489A (ja) | 2009-04-14 | 2010-11-04 | Hitachi Medical Corp | メタボリックシンドローム改善情報演算システム、当該システムとして機能させるためのプログラム、及び、当該プログラムを記録した記録媒体 |
| JP2013109700A (ja) | 2011-11-24 | 2013-06-06 | Zenrin Datacom Co Ltd | 健康管理支援装置、健康管理支援方法および健康管理支援プログラム |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023098732A (ja) | 2023-07-10 |
| JP2024052717A (ja) | 2024-04-11 |
| JP2023158148A (ja) | 2023-10-26 |
| JP2024052718A (ja) | 2024-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2006252260B2 (en) | Home diagnostic system | |
| JP2023181403A (ja) | 情報処理方法、情報処理装置及びプログラム | |
| Mori et al. | Prognostication of the last days of life | |
| Garcia | Plan-cook-eat: a meal planner app with optimal macronutrient distribution of calories based on personal total daily energy expenditure | |
| Fakhri et al. | Factors affecting patients' preferences for and actual discussions about end-of-life care | |
| Goldstein et al. | Understanding women veterans' preferences for peer support interventions to promote heart healthy behaviors: A qualitative study | |
| Gabelhouse et al. | Traditional versus hybrid outpatient cardiac rehabilitation: a comparison of patient outcomes | |
| Taniguchi et al. | Outpatient nursing support for self-monitoring in patients with chronic heart failure | |
| JP7333679B2 (ja) | 医療支援装置、医療支援方法及び医療支援プログラム | |
| Kodiath et al. | Improving quality of life in patients with heart failure: an innovative behavioral intervention | |
| Douma et al. | Patient-reported preferences in eHealth-based cardiac rehabilitation: A qualitative investigation of behavior change techniques, barriers and facilitators | |
| JP7479103B2 (ja) | 医療支援装置、医療支援方法及び医療支援プログラム | |
| de Boer et al. | Cardiopulmonary exercise testing | |
| Oka et al. | Perceptions of physical fitness in patients with heart failure | |
| JP5378814B2 (ja) | 保健指導支援用プログラム、保健指導支援用プログラムを記録した記録媒体および保健指導支援システム | |
| Brinkley et al. | Targeting obesity to optimize weight loss in cardiac rehabilitation: a pilot study | |
| Rørtveit et al. | Risk, uncertainty and ignorance in medicine | |
| JP2004355328A (ja) | 健康管理支援装置、健康管理支援システム、健康管理支援方法および健康管理支援プログラム | |
| US20230352184A1 (en) | Health support apparatus, health support method, and program | |
| Matsuo et al. | Association of residency training with metabolic measures | |
| JP7782898B1 (ja) | 健康診断レポート作成システム、健康診断レポート作成方法 | |
| Garcia et al. | Evidence of validity and accuracy for the Mindful Self-Care Scale-Brief among family caregivers of people with cancer in Brazil: A cross-sectional study | |
| Annunziato et al. | An empirically supported framework for addressing pediatric nonalcoholic fatty liver disease in outpatient care | |
| Capellari et al. | Knowledge and attitude: profile of diabetics in dialysis/Conhecimento e Atitude: perfil de pessoas com diabetes em dialise/Conocimiento y actitud: perfil de personas con diabetes en diálisis. | |
| JP2025022105A (ja) | 行動管理支援プログラム、行動管理支援装置、行動管理支援方法、及び記録媒体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230410 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230410 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20230609 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230714 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20230727 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230807 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7333679 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |